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Abstract 
Supply chain (SC) management implies a large number of interactions and a great deal of cooperation between the organizations that make up the 
supply chain in order to fulfill the purposes of logistics processes such as supply, distribution and warehousing. Much research has been carried out 
to illustrate the advantages of coordinating these processes at different stages of supply chain planning. However, these studies appear to be separate 
efforts. This study proposes methodological guidelines for the coordinated planning of the supply chain in the context of the healthcare services, 
considering the global benefits to its members by using primary information collected at several health service institutions. The proposal also includes 
a mixed-integer programming model to show how organizational coordination contributes to a reduction of the overall costs throughout the chain. 
 




Lineamientos estratégicos para coordinación en la cadena de 
suministro de medicamentos y propuesta de un modelo matemático 
para medir los efectos de la coordinación 
 
Resumen 
La gestión de la cadena de abastecimiento implica la articulación intra e inter organizacional de las áreas funcionales participantes en los procesos de 
aprovisionamiento, almacenamiento y distribución a través de las organizaciones que la componen. Diversas investigaciones se han realizado 
mostrando las ventajas de la coordinación de estos procesos en diferentes etapas de la planeación de la cadena de abastecimiento, sin embargo, 
parecen ser enfoques separados. Este artículo propone pautas metodológicas para la planeación coordinada de la cadena de suministro en el contexto 
de la prestación de servicios de salud considerando beneficios globales para sus integrantes a través de información primaria recolectada en varias 
instituciones prestadoras de servicios de salud, proponiendo también un modelo de programación lineal para mostrar los efectos de la coordinación 
en la disminución de los costos globales de la cadena. 
 




1.  Introduction 
 
In line with the progress made in economic and 
productive systems, operations management has turned into 
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a set of increasingly complex tasks, which imply the 
articulation of organizational processes according to the 
goals and expectations of the supply chain directors and 
stakeholders. 
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Industries went from focusing on mass production to 
focusing on customization. Operations strategies were 
developed such as just-in-time systems, total-quality 
management, flexible manufacturing, lean Systems, process 
outsourcing, and supply-chain management systems, among 
others [1]. Each of these strategies has been addressed from 
a planning and practice perspective, yielding operations 
management models and control schemes that make use of 
mathematical techniques. 
Operations management has evolved from a set of 
separate activities into a single integrated application within 
the management of supply chains (SC). SC can be defined as 
the set of suppliers, producers, and distributors that interact 
in order to deliver a product or to provide customer service, 
including the customer as a part of the chain, and also 
contemplating the stakeholders that are affected or involved 
in the operations of the members of the chain [2]. SC has been 
addressed using various approaches, such as risk 
management, agile SC, lean SC, Flexible SC, global SC and 
regional SC, among others [3]. Different models have been 
proposed considering isolated activities or different functions 
of the SC; however, such models appear to be fragmented 
efforts [4]. 
Researchers have mainly focused on generating models 
and solutions aimed at providing strategies and models for 
the goods industry. More recently, their attention has shifted 
towards the service sector; however, there is a lack of 
research results in activities derived from the healthcare 
service in countries like Colombia. 
In Latin America and the Caribbean, the service sector 
accounts for about 60% of both GDP (gross domestic 
product) and the total employment pool in the region. 
Although the service sector’s share has increased, its growth 
remains low when compared to other sectors of the economy 
[5]. In Colombia, the service sector presented the largest 
reported increase in revenue in 2013, with a growth of 38.4% 
over the previous year [6]. With the development of the 
sector, new opportunities arise to improve the perception of 
the services provided and therefore improve productivity. 
The service sector and its importance in the economy lies 
in its potential for regional development and job-vacancy 
creation. This sector generates around 50% of GDP in low-
income countries and, usually, its growth is linked to the 
country’s development [7]. Within the service sector, health, 
as one of its main components, exhibits "special features 
from the normative and practical context that directly affect 
the quality of the service provided to patients, namely it is not 
enough to guarantee the procedures for the detection and 
diagnosis of particular disease but it is also necessary to 
ensure the timely  availability and good condition of drug 
stocks, which  may represent a critical factor for the proper 
treatment of patients" [8].  
In today’s competitive environment, several medical 
organizations have taken the necessary actions to ensure they 
are providing the best care at the lowest possible cost [9]. 
Traditionally, the pharmaceutical industry has focused on the 
development of new medicines, on promoting alternative 
sales strategies, and on modern marketing activities. More 
recently, the industry’s attention has turned to SC 
optimization as a means of delivering added value [10]. SC 
management within the health-care sector has become ever 
more complex due to the integration of several regulation 
entities (i.e. governmental agencies) as well as the 
monopolization of markets and the requirements of patients. 
This article shows the results of a study conducted by the 
“Society, Economy and Productivity” (SEPRO) research 
group at Universidad Nacional de Colombia. The study was 
funded by Colciencias within the scope of a project entitled 
“A methodological proposal for the definition of policies, 
negotiation rules, and coordination activities applied to 
oncological medicine supply management in Colombia”. The 
present paper provides a set of guidelines to achieve the 
coordination of agents in the SC as well as a mathematical 
model that serves as a mechanism to verify the impact of 
agents’ coordination. The project’s primary information, 
obtained from various institutions providing healthcare 
services in Bogotá, was collected and analyzed to identify 
potential structures or strategic guidelines for SC 
coordination. Subsequently, a mixed-integer programing 
model is proposed to illustrate the potential benefits of 
coordination using SC global cost as a metric to quantify 
improvements.    
Section 2 contains a review of relevant research literature. 
Section 3 gathers a set of guidelines for the coordination of 
agents in SC. The proposed model to verify the potential 
effects of coordination is presented in section 5. The results 
that measure the impact of coordination and its associated 
effects appear in Section 6. Finally, Section 7 presents 
various points for further discussion. 
 
2.  Literature review 
 
Commonly, two types of structures for SC management 
are suggested depending on the degree of control that every 
SC agent has over the others, namely a centralized structure 
and a non-centralized structure. When each member of the 
chain carries out its planning individually, regardless of other 
actors, local optima do not always contribute to achieving the 
overall objectives of the SC. Instead, coordinated SC 
planning has shown to have a positive impact on some 
performance metrics [11] such as delivery times, production 
costs, customer service perception [12]. Additionally, 
coordinated SC planning reduces the overall SC costs [13]. 
Such coordination involves not only the implementation of 
enterprise resource planning systems (ERP) and its 
associated links [14], but also the joint planning processes 
and the development of synchronized forecasts [15]. 
Coordination requires breaking down communication 
barriers and overcoming the reluctance to share information, 
it also requires aligning the different interests and 
management styles. All these requirements allow  
coordination to move towards an integrated management of 
chains that ultimately replaces any other functional process 
management approach [16]. Coordination is reflected when 
the members of a SC jointly minimize operating costs and 
share profits after production planning policies and 
programming operations have been deployed [17]. 
Typically, the literature distinguishes several strategies to 
achieve coordination of operations in an SC (e.g., purchasing 
policies, bulk discounts, inventory management, and lot 
sizes). However, few of these approaches have been applied 
to the sector of pharmaceutical SC (Medicines and medical 
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supplies) in Latin American countries. 
The structure of pharmaceutical SC includes one or more 
of the following actors: primary manufacturing industries, 
secondary manufacturing industries, warehouses and 
distribution centers, wholesalers and retailers (i.e., hospitals) 
[10]. Pharmaceutical SC management is highly complex and 
sensitive since any change in the level of customer service is 
unacceptable and so demands great responsibility to ensure 
that the right drug reaches the right patient at the right time 
in the right condition [18]. Pharmaceutical SC management 
has to deal not only with the upstream information flow, such 
as market demand, but also with the downstream flow of 
technical information that supports demand creation [19]. 
Additionally, there is the challenge of reconciling the 
freedom of health professionals in writing their prescriptions 
and favoring the preferences of the hospital’s purchase 
department when offered bulk discounts [20]. Another 
challenge lies in the high levels of uncertainty associated to 
pharmaceutical demand along with the short life cycle of 
products due to their physical-chemical characteristics [21]. 
From the perspective of logistics activities, it is common 
to find proposals in the literature dealing with 1) overall 
planning of the SC in the pharmaceutical/medical industry 
focused on facility location; 2) chains of two or more levels 
presenting the case of inventory management between 
wholesalers, distributors and healthcare service provider 
institutions (IPS); and 3) optimal order quantity focused on 
the application of volume discounts, determination of the 
number of orders, and reorder point policies. 
In terms of the number of studies in the current literature 
concerning SC in the health sector, researchers have focused 
on the purchasing process and supply management, 
distribution and production of pharmaceutical products, 
health logistics, and research and development of new 
products [22]. Most of the work conducted in science, within 
pharmaceutical and medical SC management, refers to the 
overall planning and focuses on developing better solutions 
for large-scale challenges; however, it is necessary to develop 
practical models that can quickly solve the problems 
associated to the pharmaceutical SC. Such models should be 
easy to implement and should not omit the real aspects of the 
problem [23]. From the perspective of SC operations and 
management, research in the health sector focuses on 
generating strategies and objectives of operations, planning, 
scheduling, and control of services [24]. 
Regarding recent studies about SC in health care, 
Narayana, Kumar Pati & Vrat [22] conducted an extensive 
review of the recent literature that addresses the issue of 
managing pharmaceutical supply chains (PSC), showing the 
growing interest of researchers in using information 
technology, analysis and process optimization. Susarla & 
Karimipresent  presented a model of mixed integer linear 
programming for global planning multi-period, multi-level 
supply chains within the pharmaceutical industry, also 
contemplating purchasing, production and distribution 
processes [23]. Uthayakumar & Priyan developed a model 
that includes the integrated planning of two levels of the SC 
to optimize inventory, also considering the customer service 
level and showing the possibility to reduce inventory costs 
while maintaining service levels near 100% [18]. Sousa, 
Shah & Papageorgiou proposed a model for the Global 
Optimization of SC in the pharmaceutical industry, 
considering production factors and investment capacity for 
facility location [25]. Kelle et al. proposed  policies for 
reorder points and security levels with space restrictions in 
the pharmaceutical industry SC from the perspective of a 
hospital [20]. Masoumi, Yu & Nagurney developed a 
multiproduct model for optimal allocation of resources for 
the production of vaccines and medicines in the design of the 
SC [26]. 
In Colombia, it is only recently that have researchers 
become interested in the SC of the healthcare sector. By 
consulting specialized databases, it is possible to corroborate 
that there are only a few research and scientific publications 
dealing with the mechanisms that allow a visualization of the 
effects of supply chain coordination in the context of 
healthcare service provision. Castrellón, Torres & Adarme 
proposed a model for reducing the costs of logistics 
operations in the distribution of medicines in Colombia [27]. 
Zamora presented a model for risk management in the 
procurement process of oncologic drugs [28], Balcázar 
presented a methodology for the coordination of agents in 
oncology medicines SC [8]. 
Based on the content of the studies above, it is possible to 
identify a couple of gaps in the development of the research 
on SC coordination in healthcare, namely a lack of guidelines 
intended to improve coordination, and the corresponding 
mathematical models to measure the impact of such 
coordination. The following section presents various 
guidelines that can be used to coordinate processes within an 
SC. 
 
3.  Guidelines for coordination 
 
SC coordination implies the articulated and harmonized 
actions of the organizations involved in the particular SC. 
These actions should promote value creation and the 
reduction of losses. To achieve coordination of logistic 
processes, high levels of standardization and communication 
are necessary to facilitate trust between the chain members 
(Fig.1). 
It is possible to identify several strategic guidelines that 
can be used to achieve coordination in SC planning. Some of 
the main strategic guidelines, identified through our 
fieldwork with multiple healthcare institutions, are included 
in the following paragraphs. 
The coordination process depends on the implementation 
and the proper use of information technology as well as the 
use of suitable systems for warehouse management (WMS). 
Real-time information on inventory levels and availability of 
resources (for the handling and transporting medicines) 
facilitates tactical and operational planning. 
 
 
Figure 1. Road to coordination 
Source: The Authors. 
 






Balcázar-Camacho et al / DYNA 83 (197), pp. 203-211. June, 2016. 
206 
The deployment strategy for coordination begins with a 
diagnostic phase. This initial phase is intended to identify the 
information needs of the processes that must be integrated, 
the characteristics of the tangible and intangible elements of 
the participants and also to determine the team members that 
generate joint operation plans. These members are 
responsible for conducting the necessary logistical 
coordination during the planning horizon (Fig.2). Thus, it is 
necessary to determine various additional aspects, such as the 
structure of the communication channels, the main generators 
of information, the power levels for decision-making, the 
command channels, the response times, and the responsible 
members in charge of each process together with their 
substituting members (when required). Once the instructions 
and manuals have been settled, this information should 
mitigate the effects of plausible contingencies as well as of 
any deviation from the plans. These actions contribute to 
having minor adverse effects and delays in operations. 
The equipment for SC planning must be composed of 
delegates from all the organizations (that participate in the 
process of harmonization and coordination) and 
professionals of all organizational levels, who know the 
details of each process in the logistic cycle (Fig. 3). 
Planning for the coordination of activities in the SC must 
help identify redundant and concordant issues both in the 
operation and in the planning horizons of all organizations. 
Such planning should also match every activity according to 
the business strategy of each business unit. The redundant 
activities must be eliminated by considering which particular 
activity has the lesser impact on value creation, i.e., duplicate 
efforts can cause delays and become non-value adding 
activities. Therefore, in each process of the logistic cycle, 
activities should be checked in detail, e.g., inspections, 
checks, temporary storage, use of packaging and secondary 
packaging, signage and marking of products, among others. 
In an ideal scenario, a high degree of coordination planning 
(for the supply, storage and distribution of all organizations of 
the chain) allows us to identify the impact of coordination on 
the logistics network and to determine the best location of 
inventories based on aspects such as demand, availability of 
resources and capacity of production and storage. It is possible 
to obtain advantages in the overall SC planning by using a 
midpoint in the chain as a reference (either manufacturing or 
distribution) for the exchange of information. Such a midpoint 
can then be used as a centralized decision-making spot or as an 
inventory centralized management spot, allowing better 
decision making and achieving global cost reduction [12,28]. 
 
 
Figure 2. Deployment strategy for coordination. 
Source: The Authors. 
 
Figure 3. Planning for coordination. 
Source: The Authors. 
 
 
It is necessary to establish control mechanisms and 
improvement measures for the activities and integrated 
processes in order to evaluate the degree of coordination 
achieved so far, as well as the advantages or benefits in terms 
of organizational goals. These performance indicators may 
include: 
* Number of processed orders/number of received orders. 
* Delays in execution of orders or average waiting times. 
* Joint use of means of labor/Means of labor available. 
* Savings on the use of primary or secondary packaging 
and wrapping. 
* Overbooking savings (over-execution of budget to meet 
unplanned orders). 
Achieving economies of scale, incentives for volume and 
quantity discounts may represent motivating factors to 
initiate processes of inter-organizational coordination. In 
logistics, coordination strategies regarding the size of lots, 
common or joint replenishment times, purchasing pools, joint 
negotiations for contracting support services (e.g., security 
services, locative maintenance, transportation, marketing, 
etc.) or logistics operators, are procedures available to all 
organizations without requiring major structural or 
background changes in their operations. 
To achieve inter-organizational coordination, it is first 
necessary to have a high degree of internal coordination 
within each of the organizations in the SC. This is to say that 
the areas within each organization (namely distribution, 
supply and warehouse)  must be aligned with its own 
particular business strategy and also simultaneously with the 
whole-chain strategy [2]. Both the joint goals that motivate 
the articulation and coordination of operations and the 
organizational goals must be aligned with the overall goals of 
the chain. This, in turn, generating a management cycle that 
requires constant updating and revision by the joint planning 
management team. 
 
4.  Context of the medicines supply chain 
 
In the pharmaceutical industry, it is common to find supply 
chains of multiple levels depending on the degree of 
intermediation required for the acquisition and adequacy of 
medicines. This is particularly true in the case of oncology 
drugs, which must be conditioned prior to application to the 
patients. In Colombia, not all institutions providing health 
services (IPS) have the facilities and the necessary certifications 
Initial Diagnosis 
Conformation of Joint planning team 
Identification of information needs 
Harmonization Plan  
Evaluation and adjusment 
Extension and socialization 
 
Execution and control 
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Figure 4. Oncology drugs SC Structure  
Source: The Authors. 
 
 
for the proper conditioning of drugs. Therefore, IPS must rely 
on outsourced services provided by specialized mixing 
centers, which are responsible for collecting, reconditioning 
and redistributing medicines to their customers (Fig. 4). 
The SC of medicines and medical supplies has special 
characteristics that regulate its management and operation. 
First, given the high cost of some medicines and their 
physical-chemical characteristics that determine specific 
storage conditions, it is necessary to ensure the existence of 
a cold chain for many of these medicines. In addition, at 
every IPS, the people responsible for logistics processes may 
not have the required experience in areas such as inventory 
management, procurement of stock, or the use of demand 
prediction techniques. Most importantly, the majority of IPS 
lack WMS systems to facilitate their work. The risk of 
shortages, or medicine stock-outs, leads to having specialists 
prescribing medicines subject to availability and cost criteria. 
Such restrictions promote the use of substituting, less-
effective medicines that match the procurement plans of 
particular institutions (e.g. IPS). 
In the case of oncological medicines in Bogotá, and based 
on fieldwork carried out through surveys and interviews in 
45 IPS that provide oncological services, it was possible to 
determine the following relevant aspects regarding the 
management and logistic activities in the health-care SC: 1) 
the schedule for the application and in-hospital drug 
distribution is made mostly with daily frequency at specific 
times, 2) not all IPS have information systems that show the 
real-time status of medicines inventories , 3) very few IPS 
have indicators to allow monitoring of logistics management, 
4) Only 22% of respondents  perform audits to the process of 
distribution and administration of oncology drugs, and 18% 
have improvement plans for the distribution process and 
management of their inventories. 
Additionally, it was determined that there are multiple 
ways to purchase: according to historical demand, according 
to budget, and according to epidemiological profiles or care 
plans. Regarding the integration of logistics activities, it was 
possible to identify that some IPS have begun to work in 
conjunction with wholesaler distributors by implementing 
pharmacies that operate inside the corresponding IPS. 
 
5.  Mathematical model for measuring the effects of 
coordination 
 
We developed a mixed integer linear programing model 
to show the potential benefits of coordination in the health-
care SC. The model considers global cost of inventory and 
physical flows in the chain. The main idea is to choose the 
position of inventory levels as a function of three factors, 
namely demand, capacity and cost. The model assumes 
known cost structures as well as known demands and 
capacities. In order to choose the best mix of providers to 
deliver medication to the patients while minimizing the 
overall costs of the chain, the model provides a structure in 
which  i (i=1,.., m.) suppliers provide type-p drugs (p=1,.., q.) 
to k (k=1,.., K.) IPS over t (t=1,.., T.) periods to be applied to 
j (j=1,.., n.) patients (Fig. 5). 
The model parameters are: 
, Fixed transport cost from the supplier i to IPS k. 
, 	Variable cost of transporting one unit of single type 
drug reference p from supplier i to IPS k.	
Inventory cost associated to holding one unit of drug 
p at supplier i at period t.	
, Supply capacity of supplier i to deliver drug p at 
period t. 
, , Maximal trips available at period t from supplier i 
to IPS k.	
, Warehouse space of Supplier i at period t. 
Inventory cost associate to holding one unit of drug p 
at IPS k.	
, Warehouse space of IPS k at period t.	
, Demand of drug p necessary for patient j at period t.	
Purchase price of drug p.	
, Budget of IPS k at period t to buy drugs.	
Space required to store one unit of product p.	
Space required to transport one unit of product p.	
Cargo capacity of the transport medium.	
The model’s variables are: 
, , Units of drug p sent from supplier i to IPS  k  at period 
t.	
, , Units of drug p delivered to the patient j at IPS k at 
period t.	
, Inventory level of drug p held by supplier I at period t.	
, Inventory level of drug p held by IPS k at period t.	
, , Number of trips from supplier i to IPS k at period t.	
 
The objective function is: 
	
Min , , ∗ , ,
111
, , ∗ , ,
1111
 
						 , ∗ , ,
∗ , 				 0 	
 
The constraints are: 
 
, , 	 		 , , , ∀ , , 																																				 1 			 
, , , 	 	 , , , ∀ , , 																												 2 		 
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The Objective function (0) includes the fixed cost of 
transport according to various factors, namely the number of 
trips made, the variable cost of transportation and the cost of 
inventory from suppliers and IPS. 
Constraint (1) represents the balance between the flows 
of medicines of supplier i. This constraint also establishes 
that the amount of inventory of medication p in supplier i at 
period t equals the amount of type-p drug available plus the 
inventory of type-p drug at period t-1, minus the amount of 
drug p sent to IPS k. 
Constraint (2) represents the balance between the flows of 
drugs at IPS k. This constraint states that the amount of p-type 
drug inventory at IPS k, in time period t, is equal to the amount 
of p-type medication received from suppliers in the same 
period, plus the type-p drug inventory from period t-1, minus 
the amount of drug p given to patient j during the t period. 
Constraint (3) shows the balance of type-p drugs required 
for patient j and the amount delivered from IPS k at period t. 
Constraint (4) guarantees that the amount of type-p drug 
to be sent to IPS k cannot exceed the quantities of type-p drug 
available at supplier i at period t. 
Constraint (5) guarantees that the amount of all drugs 
stored in IPS k at period t cannot exceeded the available 
space.    
Constraint (6) guarantees that the amount of all drugs 
stored at supplier i at period t cannot exceeded the available 
space.    
Constraint (7) ensures that the total volume occupied by 
the drugs to be transported from supplier i to IPS k at period 
t is less than or equal to the number of trips that can be 
handled by the volume capacity of the transport medium. 
Constraint (8) ensures that the number of scheduled trips 
from supplier i to IPS k at period t is less than the amount of 
allowable trips between these two locations for the same 
period. 
Constraint (9) ensures that the total purchase cost 
assumed by  IPS k is less than or equal to the total budget in 
period t. 
Constraint (10) ensures that all decision variables are non-
negative and integer. 
 
Likewise, the initial conditions are established: 
 
,0 A1∀		 1, . . , 		 1, . . , 				
 
,0 A2∀		 1, . . , 		 1, . . , 	
 
Where A1, A2 represent the initial inventory levels. 
And final conditions: 
 
, A3		∀		 1, . . , 		 1, . . , ;									
 
A3 represents the desired level of inventory at the end of 
the planning horizon T. 
 
6.  Results  
 
To show that coordinated planning can improve the 
performance of the supply chain, the  mathematical model of 
mixed integer linear programming, presented in section 5, 
was used to compare two scenarios with varying  demand 
distributions in the same planning horizon. Patient care is 
performed under the assumption of coordination involving a 
free flow of information and cooperation to satisfy demand 
in the first scenario; and the assumption of non-cooperation 
in the second scenario, where demand exceeds the capacity 
and should be deferred. 
Emulated data resembling real data was used in order not 
to compromise the organization's private data. The main 
objective of the proposed model is to show the potential 
benefits in terms of global SC cost reduction resulting from 
information sharing in the attention planning process. 
To run the proposed model, a sample instance with 3 
suppliers, 2 IPS, and 7 patients (requiring 3 types of drugs), 
in a planning horizon of 5 periods of time was solved. To this 
end, the mathematical modeling package GAMS was used; 
specifically, the CPLEX solver was run on a machine with a 
Core i5 processor of 2.67 GHz and 4 GB RAM. The demand 
distribution data is presented in Table 1. 
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Figure 5. Model  Structure.  
Source: The Authors. 
 
 
To run the model, the following assumptions hold: 1). 
The fixed and variable costs of supplier 1 are higher than 
those of provider 2 and, in turn, the costs of supplier 3 are 
higher than those of provider 2. 2) The costs of keeping type-
p drugs in inventory are 4, 2 and 1 percent the price of the 
corresponding drug for suppliers 1, 2 and 3, respectively. 3) 
The cost of maintaining a type-p drug in the IPS inventory is 
80% of the product’s price, since a drug suitable for one 
patient is rarely appropriate for another. 4) The space to store 
drugs in the oncology department at the IPS is limited. 5) The 
means of transportation from the supplier to the IPS has 
limited capacity. 6) A one-to-one linear relationship is 
assumed between drugs and patients. 
Two scenarios were proposed to show the effects of 
coordination in terms of global SC cost. The baseline 
scenario assumes uncoordinated patient attention ignoring 
capacity restrictions of IPS. The modified scenario assumes 
coordination for patient attention. The results of the two 
scenarios show a reduction in the overall costs of the chain of 
16.33% due to a variation in the behavior of inventories. 
Demand leveling across various planning periods as a 
result of the joint planning process contributes to avoiding 
bottlenecks and shortages of capacity in order to better cope 
with patient attention in the proposed scenarios. The model 
shows how, by varying only the demand in the different time 
periods of the planning horizon (i.e. rescheduling patient 
appointments), it is possible to achieve lower costs as a result 
of the changes in inventory levels (see Table 3 and Table 4). 
In real life, members of the SC would be able to achieve 




Patients (p) attended by period (t) in baseline and modified scenarios and 
drug required. 
   Baseline       Modified     Drug 
p\t 1 2 3 4 5   1 2 3 4 5   1 2 3 
1 0 0 0 1 0   1 0 0 0 0   1 0 0 
2 0 0 0 1 0  0 1 0 0 0  1 0 0 
3 0 0 0 1 0  0 1 0 0 0  0 1 0 
4 0 1 0 0 0  0 0 1 0 0  0 1 0 
5 0 0 0 1 0  0 0 0 1 0  0 0 1 
6 0 1 0 0 0   0 0 0 0 1   0 0 1 
7 0 0 1 0 0   0 0 0 0 1   0 0 1 




Minimum overall cost of the chain in each scenario. 
Baseline   Modified   Savings 





Behavior of inventories in the base scenario. 
  Drug t1 t2 t3 t4 t5 
Supplier1 P1 1 1 4 5 5 
 P2 0 0 4 4 4 
  P3 1 3 3 4 6 
Supplier2 P1 0 0 0 1 1 
 P2 1 1 2 2 3 
  P3 0 1 1 2 2 
Supplier3 P1 0 2 2 2 2 
 P2 0 0 4 4 4 
  P3 1 2 2 2 3 





Behavior of inventories in the Modified scenario. 
  Drug t1 t2 t3 t4 t5 
Supplier1 P1 0 0 3 4 4 
 P2 0 0 4 4 4 
  P3 1 5 5 6 6 
Supplier2 P1 0 0 0 2 2 
 P2 1 1 2 2 3 
  P3 0 1 1 2 2 
Supplier3 P1 0 1 1 2 2 
 P2 0 0 4 4 4 
  P3 1 2 2 2 3 




7.  Discussion and recommendations 
 
By comparing the proposed scenarios, it is possible to 
show that coordination in the SC can have significant effects 
in reducing overall chain costs. However, it is not enough to 
implement strategies and mechanisms that contemplate only 
an isolated logistic chain process. It is, therefore, necessary 
to conduct an integrated planning that allows the articulation 
of multiple processes based on global achievements for the 
chain, such as economies of scale, eliminating duplicate 
efforts and waste minimization. Our example shows how, by 
simply sharing information, it is possible to achieve cost 
reduction. Future research is necessary to find out how to 
share the benefits,fairly among all the SC members. 
To achieve coordination through the SC, standardization 
of processes and procedures as well as the use of similar 
information systems that are easily bondable may be a 
contribute to facilitating the exchange of information for the 
joint planning of the logistics activities and also to controlling 
the inventory levels across the chain. 
In this paper, we have presented a set of methodological 
guidelines that can be applied to achieve coordination of 
activities in the SC. Furthermore, to show that such 
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overall costs of the chain, we used   a model of mixed integer 
linear programming that applies to similar contexts and 
serves to illustrate the potential effects of coordinated 
operations. 
To achieve a practical approach to implementating the 
guidelines presented, there must be a high degree of 
commitment and trust between members of the SC to share 
information about their processes and engage in joint 
planning processes. For Future research, we suggest 
simulation scenarios that consider agreements and revenue-
sharing contracts, showing the benefits that can be 
accomplished when sharing the savings that result from the 
coordination of activities in the logistics context. 
In Colombia, the extension and appropriation of recent 
developments in the theory of SC management can have a 
great impact on the planning of logistics activities within 
medical institutions, leading to their improvement and thus 
contributing to improving the services delivered to the 
patient. The development of programs or partnerships that 
enable and facilitate the interaction of professionals and 
researchers in logistics areas, within health institutions and 
control agencies, is needed to generate logistics management 
methodologies, mechanisms and policies that suit the needs 
of the healthcare sector, thus facilitating coordination for the 
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